CoChat
Sign Up
Cited by 315Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studiesHIV-related health complications and treatments

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

Binnerts, Arjen, Swart, G. Roel, Wilson, J. H. Paul, Hoogerbrugge, Nicoline, Pois, Hulbert A. P., Birkenhager, Jan C., Lamberts, Steven W. J.·1992·Clinical Endocrinology
DOI 10.1111/j.1365-2265.1992.tb02287.x
Open this paper in CoChat — free account

Abstract

OBJECTIVE: The effect on bone, protein, carbohydrate and lipid homeostasis as well as body composition of the administration of growth hormone to adult patients with growth hormone deficiency was studied. DESIGN: Growth hormone was administered at a dose of 25 micrograms/kg/day with a maximum of 1.48 mg (4 IU) a day, for 6 months in eight adults. Studies were done before the start and at 1, 3 and 6 months during therapy, as well as 3 months after treatment had been stopped. RESULTS: Subjective well-being as assessed by a short psychological tests showed an improvement in six and no change in two patients. Body composition, as assessed by body impedance assessment and D2O dilution, both showed an increase in lean body mass of 4 kg (5% of body weight), accompanied by a decrease in mean fat mass of 3 kg. Nitrogen turnover studies showed a transient increase in fed state nitrogen balance due to an increase in the rate of protein synthesis, which exceeded a smaller increase in the protein degradation rate. Growth hormone treatment did not affect the circulating levels of 25(OH)-vitD or PTH 1-84, while 1,25(OH)2-vitD had significantly increased after 6 months, as well as 3 months after treatment ended. Osteocalcin, procollagen I levels, as well as 24-hour urinary excretion of hydroxyproline and calcium rose during growth hormone administration but subsequently decreased rapidly after administration had been stopped, while the increase in alkaline phosphatase persisted. This increase in markers of both bone resorption and bone formation indicates an activation of bone remodelling, but this was not reflected by an increase in bone density. Glucose levels, measured before and during a normal breakfast, increased during growth hormone treatment, but serum insulin levels did not. Total cholesterol levels decreased by 0.5 mmol/l. Levels of T4 and free T4 as well as rT3 decreased, while T3 increased during growth hormone treatment. CONCLUSION: Therapy with growth hormone for 6 months in a dose varying between 6 and 25 micrograms/kg/day increased lean body mass and decreased fat mass. The sense of general well-being improved in most patients. Furthermore, growth hormone treatment increased bone turnover without a measurable increase in bone density, caused some minor changes in lipid and carbohydrate metabolism, and increased the metabolism of thyroxine to T3.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1992.tb02287.x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Binnerts, A., Swart, G. R., Wilson, J. H. P., Hoogerbrugge, N., Pois, H. A. P., Birkenhager, J. C., & Lamberts, S. W. J.
Affiliations
Academisch Ziekenhuis Rotterdam (NL)
Corresponding author
Lamberts, Steven W. J.
ORCID
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1992-07
Volume
37
Issue
1
Pages
79-87
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
DOI
10.1111/j.1365-2265.1992.tb02287.x
OpenAlex
W2021368986
Cited by
315
References
41
Citations by year
2026: 4 · 2025: 1 · 2024: 3 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 4 · 2017: 4 · 2015: 3 · 2014: 5 · 2013: 7 · 2012: 3
FWCI
11.97
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor, 5738 d)
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
Keywords
growth hormone therapy, adult growth hormone deficiency, body composition, lean body mass, fat mass, bone turnover, bone remodeling, bone mineral density, nitrogen balance, protein metabolism, carbohydrate metabolism, lipid metabolism, vitamin D, parathyroid hormone, osteocalcin, thyroxine metabolism, T3, well-being
MeSH terms
Adult, Blood Glucose, Body Composition, Female, Health Status, Homeostasis, Humans, Hypopituitarism, Insulin, Lipids, Male, Middle Aged, Nitrogen, Proteins, Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review